Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Staphylococcus aureus α-Toxin Response Distinguishes Respiratory Virus-Methicillin-Resistant S. aureus Coinfection in Children.

Yu KO, Randolph AG, Agan AA, Yip WK, Truemper EJ, Weiss SL, Ackerman KG, Schwarz AJ, Giuliano JS Jr, Hall MW, Bubeck Wardenburg J; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) PICFlu Study Group; PALISI PICFlu Study Group.

J Infect Dis. 2016 Dec 1;214(11):1638-1646. Epub 2016 Sep 20.

2.

Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.

Liu X, He Y, Xiao K, White JR, Fusco DN, Papanicolaou GA.

PLoS One. 2013;8(3):e57483. doi: 10.1371/journal.pone.0057483. Epub 2013 Mar 5.

3.

Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893.

Tabor DE, Yu L, Mok H, Tkaczyk C, Sellman BR, Wu Y, Oganesyan V, Slidel T, Jafri H, McCarthy M, Bradford P, Esser MT.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5312-21. doi: 10.1128/AAC.00357-16. Print 2016 Sep.

4.

Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Sharma-Kuinkel BK, Wu Y, Tabor DE, Mok H, Sellman BR, Jenkins A, Yu L, Jafri HS, Rude TH, Ruffin F, Schell WA, Park LP, Yan Q, Thaden JT, Messina JA, Fowler VG Jr, Esser MT.

J Clin Microbiol. 2015 Jan;53(1):227-36. doi: 10.1128/JCM.02023-14. Epub 2014 Nov 12.

5.

Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection.

Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, Fry A, Hageman J, Gorwitz R, Bresee J, Uyeki T.

Pediatrics. 2008 Oct;122(4):805-11. doi: 10.1542/peds.2008-1336.

PMID:
18829805
6.

α-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia.

Stulik L, Malafa S, Hudcova J, Rouha H, Henics BZ, Craven DE, Sonnevend AM, Nagy E.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1139-48. doi: 10.1164/rccm.201406-1012OC.

PMID:
25303310
7.

Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.

Nguyen T, Kyle UG, Jaimon N, Tcharmtchi MH, Coss-Bu JA, Lam F, Teruya J, Loftis L.

Crit Care Med. 2012 Dec;40(12):3246-50. doi: 10.1097/CCM.0b013e318260c7f8.

8.

Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.

Wu Y, Liu X, Akhgar A, Li JJ, Mok H, Sellman BR, Yu L, Roskos LK, Esser MT, Ruzin A.

Infect Immun. 2018 Feb 20;86(3). pii: e00671-17. doi: 10.1128/IAI.00671-17. Print 2018 Mar.

9.

Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children.

Reed C, Kallen AJ, Patton M, Arnold KE, Farley MM, Hageman J, Finelli L.

Pediatr Infect Dis J. 2009 Jul;28(7):572-6. doi: 10.1097/INF.0b013e31819d8b71.

PMID:
19478685
10.

Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.

Tkaczyk C, Kasturirangan S, Minola A, Jones-Nelson O, Gunter V, Shi YY, Rosenthal K, Aleti V, Semenova E, Warrener P, Tabor D, Stover CK, Corti D, Rainey G, Sellman BR.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00629-17. doi: 10.1128/AAC.00629-17. Print 2017 Aug.

11.
12.
13.

Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.

Wu D, Wang Q, Yang Y, Geng W, Wang Q, Yu S, Yao K, Yuan L, Shen X.

Diagn Microbiol Infect Dis. 2010 May;67(1):1-8. doi: 10.1016/j.diagmicrobio.2009.12.006. Epub 2010 Mar 12.

PMID:
20227225
14.

An antidote for Staphylococcus aureus pneumonia?

DeLeo FR, Otto M.

J Exp Med. 2008 Feb 18;205(2):271-4. doi: 10.1084/jem.20080167. Epub 2008 Feb 11. Erratum in: J Exp Med. 2008 Mar 17;205(3):739.

15.

Vaccine protection against Staphylococcus aureus pneumonia.

Bubeck Wardenburg J, Schneewind O.

J Exp Med. 2008 Feb 18;205(2):287-94. doi: 10.1084/jem.20072208. Epub 2008 Feb 11.

16.

Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.

Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC.

J Infect. 2007 May;54(5):427-34. Epub 2006 Oct 27.

PMID:
17070598
18.

Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.

Gonzalez BE, Hulten KG, Dishop MK, Lamberth LB, Hammerman WA, Mason EO Jr, Kaplan SL.

Clin Infect Dis. 2005 Sep 1;41(5):583-90. Epub 2005 Jul 29.

PMID:
16080077
19.

Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital.

Carrillo-Marquez MA, Hulten KG, Hammerman W, Lamberth L, Mason EO, Kaplan SL.

Pediatr Infect Dis J. 2011 Jul;30(7):545-50. doi: 10.1097/INF.0b013e31821618be.

PMID:
21407143
20.

Supplemental Content

Support Center